Why the study?
Appropriate risk stratification in pulmonary embolism, particularly for intermediate-risk patients, remains challenging despite existing clinical prediction rules.
Design
Review article
Authors
Loading...
Intermediate-risk PE stratification remains challenging; hypothesis-generating for new tools, needs prospective validation before practice change.
This review highlights the importance of a multimodality approach using clinical scores, biomarkers, and imaging for accurate risk stratification and management of acute pulmonary embolism.
Silva et al. (2023) studied this question.